Dr. Kedar Kirtane, MD
Claim this profileMoffitt Cancer Center
Area of expertise
Squamous Cell Carcinoma
Kedar Kirtane, MD has run 4 trials for Squamous Cell Carcinoma. Some of their research focus areas include:
Cancer
Kedar Kirtane, MD has run 4 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
Moffitt Cancer Center
Moffitt Cancer Center - McKinley Campus
Clinical Trials Kedar Kirtane, MD is currently running
CAR T-Cell Preparation
for Cancer
Objective: To collect information on how often a solid tumor cancer might lose the Human Leukocyte Antigen (HLA) by next generation sequencing and perform apheresis to collect and store an eligible participant's own T cells for future use to make CAR T-Cell therapy for their disease treatment. Design: This is a non-interventional, observational study to evaluate participants with solid tumors with a high risk of relapse for incurable disease. No interventional therapy will be administered on this study. Some of the information regarding the participant's tumor analysis may be beneficial to management of their disease. Participants that meet all criteria may be enrolled and leukapheresed (blood cells collected). The participant's cells will be processed and stored for potential manufacture of CAR T-cell therapy upon relapse of their cancer.
Recruiting
1 award
N/A
3 criteria
Pembrolizumab + Radiation vs Chemotherapy + Radiation
for Head and Neck Cancer
This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Carboplatin is also in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab alone after surgery may work better than the usual approach in shrinking recurrent or primary head and neck squamous cell carcinoma.
Recruiting
1 award
Phase 2
31 criteria
More about Kedar Kirtane, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Kedar Kirtane, MD has experience with
- Pembrolizumab
- Cisplatin
- Aldesleukin
- Cyclophosphamide
- Fludarabine
- Platinum Based Chemotherapy
Breakdown of trials Kedar Kirtane, MD has run
Squamous Cell Carcinoma
Cancer
Head and Neck Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kedar Kirtane, MD specialize in?
Kedar Kirtane, MD focuses on Squamous Cell Carcinoma and Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are PD-L1 positive.
Is Kedar Kirtane, MD currently recruiting for clinical trials?
Yes, Kedar Kirtane, MD is currently recruiting for 5 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Kedar Kirtane, MD has studied deeply?
Yes, Kedar Kirtane, MD has studied treatments such as Pembrolizumab, Cisplatin, Aldesleukin.
What is the best way to schedule an appointment with Kedar Kirtane, MD?
Apply for one of the trials that Kedar Kirtane, MD is conducting.
What is the office address of Kedar Kirtane, MD?
The office of Kedar Kirtane, MD is located at: Moffitt Cancer Center, Tampa, Florida 33136 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.